Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine Toxoplasma infection

被引:9
作者
BergCandolfi, M
Candolfi, E
机构
[1] Institut de Parasitologie, Faculté de Médecine, Université Louis Pasteur, Strasbourg
关键词
Toxoplasma infection; erythromycin; azithromycin; clarithromycin; clindamycin; N-demethylation; cytochrome P450 3A; mouse; liver; intestine;
D O I
10.1016/S0020-7519(96)00111-7
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The N-demethylation of macrolides was studied in a murine model of infection. Mice were infected with a cystogenic strain of Toxoplasma gondii (20 or 40 cysts/mouse) and microsomes were prepared from liver homogenates and jejunum villus tip enterocytes on day 10 post-infection. The rate of N-demethylation of the anti-Toxoplasma macrolides azithromycin, clarithromycin and clindamycin was investigated and compared to that of the macrolide erythromycin, a marker of the activity of the cytochrome P-450 3A (CYP3A) mono-oxygenases. In infected mice (20 cysts/mouse), the rate of N-demethylation fell in the liver and jejunum for erythromycin (- 25% and - 35%, respectively), azithromycin (- 12% and - 10%, respectively), clarithromycin (- 23% and - 21%, respectively) and clindamycin (- 20% and - 28%, respectively). The degree of hepatic depression was more marked in mice receiving a 40-cysts burden: for erythromycin (- 54%), azithromycin (- 29%), clarithromycin (- 49%) and clindamycin (- 47%). Copyright (C) 1996 Australian Society for Parasitology. Published by Elsevier Science Ltd.
引用
收藏
页码:1321 / 1323
页数:3
相关论文
共 22 条
  • [1] Araujo F G, 1992, Int J Antimicrob Agents, V1, P153, DOI 10.1016/0924-8579(92)90002-9
  • [2] INVIVO ACTIVITY OF THE MACROLIDE ANTIBIOTICS AZITHROMYCIN, ROXITHROMYCIN AND SPIRAMYCIN AGAINST TOXOPLASMA-GONDII
    ARAUJO, FG
    SHEPARD, RM
    REMINGTON, JS
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (06) : 519 - 524
  • [3] ACTIVITY OF CLARITHROMYCIN ALONE OR IN COMBINATION WITH OTHER DRUGS FOR TREATMENT OF MURINE TOXOPLASMOSIS
    ARAUJO, FG
    PROKOCIMER, P
    LIN, T
    REMINGTON, JS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (11) : 2454 - 2457
  • [4] ARAUJO FG, 1993, J CHEMOTHERAPY, V5, P519
  • [5] EFFECT OF CLINDAMYCIN ON ACUTE AND CHRONIC TOXOPLASMOSIS IN MICE
    ARAUJO, FG
    REMINGTO.JS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 5 (06) : 647 - 651
  • [6] Suppression of intestinal and hepatic cytochrome P4503A in murine Toxoplasma infection. Effects of N-acetylcysteine and N-G-monomethyl-L-arginine on the hepatic suppression
    BergCandolfi, M
    Candolfi, E
    Benet, LZ
    [J]. XENOBIOTICA, 1996, 26 (04) : 381 - 394
  • [7] BLACK JR, 1992, CLINDAMYCIN TREATMEN, P13
  • [8] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [9] MITOGEN-SPECIFIC AND ANTIGEN-SPECIFIC PROLIFERATION OF T-CELLS IN MURINE TOXOPLASMOSIS IS INHIBITED BY REACTIVE NITROGEN INTERMEDIATES
    CANDOLFI, E
    HUNTER, CA
    REMINGTON, JS
    [J]. INFECTION AND IMMUNITY, 1994, 62 (05) : 1995 - 2001
  • [10] TREATMENT OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS - A RANDOMIZED TRIAL COMPARING PYRIMETHAMINE PLUS CLINDAMYCIN TO PYRIMETHAMINE PLUS SULFADIAZINE
    DANNEMANN, B
    MCCUTCHAN, JA
    ISRAELSKI, D
    ANTONISKIS, D
    LEPORT, C
    LUFT, B
    NUSSBAUM, J
    CLUMECK, N
    MORLAT, P
    CHIU, J
    VILDE, JL
    ORELLANA, M
    FEIGAL, D
    BARTOK, A
    HESELTINE, P
    LEEDOM, J
    REMINGTON, J
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 116 (01) : 33 - 43